Key Takeaways ISRG shares jumped 28.5% after strong Q3 results and 20% global procedure growth. ISRG's da Vinci 5 and Ion platforms drove utilization gains and international adoption. Margin pressure, China competition, and a lofty valuation temper ISRG's near-term appeal. Intuitive Surgical’s (ISRG) shares have surged 28.5% over the past month, following a robust third-quarter performance that showcased 20% global procedure growth and accelerating adoption of its new da Vinci 5 system. Strong utilization g ...